incretin mimetic agents glp 1 receptor agonists The system: glucagon-like peptide-1 and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Non-insulin injectable antidiabetic drugs -

Fei Y, Tsoi MF, Cheung BMY

Minimal clinically important difference on the motor examination part of MDS-UPDRS

Physiology of incretins in health and disease

A single cell divides trillions of times in order to form a human, a process that continues constantly throughout life

Novo Nordisk: CagriSema Cagrilinitide is an analogue (a drug made to mimic a molecule already present in the body) of amylin, which acts as an agonist for calcitonin receptors

A percentage of people will not be able to tolerate the new pharmacotherapies or achieve the individualised goals and others may not have long-term access to these treatments